In vitro diagnostic point-of-care test devices
- Medicines and Healthcare products Regulatory Agency
- Part of:
- In vitro diagnostic (IVD) devices: use, safety and management, Medical devices: safety guidance, and Medicines and medical devices: product-specific information
- First published:
- 22 July 2005
Advice and guidance on the management and use of point-of-care testing (POCT) in vitro diagnostic (IVD) devices.
PDF, 441KB, 28 pages
This file may not be suitable for users of assistive technology. Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email email@example.com. Please tell us what format you need. It will help us if you say what assistive technology you use.
This Medicines and Healthcare Products Regulatory Agency (MHRA) guidance is for people involved in the management and use of POCT services in primary and secondary care including:
- managerial staff
- scientific staff
- clinical and nursing staff
While many of the issues are relevant to the performance of POCT in a hospital environment, the principles also apply to their use in:
- outpatient clinics
- community care
- GP practices
- community providers
- primary care settings
Published: 22 July 2005